Skip to main content
Log in

Medicines Safety Update and PI changes for administration of vinca alkaloids

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Marketed in Australia as Vincristine Sulfate Injection, DBL Vinblastine and Navelbine, and various generic brands.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Medicines Safety Update and PI changes for administration of vinca alkaloids. Reactions Weekly 1897, 5 (2022). https://doi.org/10.1007/s40278-022-11242-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-11242-2

Navigation